Did a GLP-1 Drug Cause Your Serious Injury?
Patients prescribed Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1 drugs who developed severe gastroparesis, intestinal obstruction, ileus, or sudden vision loss may have a legal claim for compensation.
GLP-1 Drugs & Serious Injuries: What You Need to Know
GLP-1 receptor agonists, including Ozempic, Wegovy, and Rybelsus (Novo Nordisk) and Mounjaro, Zepbound, and Trulicity (Eli Lilly), have become some of the most widely prescribed medications in the United States for type 2 diabetes and weight loss. Tens of millions of Americans have taken these drugs.
Lawsuits allege that these medications can cause severe gastrointestinal injuries, including gastroparesis (stomach paralysis), intestinal obstruction, and ileus (paralysis of the intestinal muscles). Plaintiffs also report persistent vomiting, severe abdominal pain, dehydration, and significant weight loss requiring hospitalization.
In December 2025, a second federal MDL (MDL 3176) was established to consolidate claims that GLP-1 drugs can cause non-arteritic anterior ischemic optic neuropathy (NAION) - a sudden, often permanent form of vision loss. Both MDLs are proceeding before Judge Karen Marston in the Eastern District of Pennsylvania.
In January 2025, the FDA approved a label update for Ozempic adding a severe-gastroparesis caution. Plaintiffs allege that Novo Nordisk and Eli Lilly knew or should have known about these risks earlier and failed to adequately warn patients and prescribing physicians.
Do You Qualify? Common Eligibility Criteria
Every case is unique and requires individual attorney review. Individuals who may have a viable GLP-1 drug claim typically meet criteria similar to the following:
✓ You May Qualify If You:
- Were prescribed Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Victoza, or Saxenda
- Were diagnosed with gastroparesis (stomach paralysis) after starting a GLP-1 drug
- Experienced intestinal obstruction or ileus requiring hospitalization
- Were diagnosed with NAION (non-arteritic anterior ischemic optic neuropathy) or sudden vision loss
- Required hospitalization, feeding tube, or surgery due to GI complications
- Diagnosis occurred during GLP-1 use or within a reasonable period after
- Within the applicable statute of limitations for your state
What Is Gastroparesis?
Gastroparesis is a condition in which the stomach cannot empty food normally due to impaired muscle function. Symptoms include severe nausea, vomiting, abdominal pain, bloating, early satiety, and unintended weight loss. Severe cases can require feeding tubes, surgical intervention, and lifelong dietary management. In lawsuits, plaintiffs allege that GLP-1 drugs caused prolonged or permanent gastroparesis that did not resolve after stopping the medication.
NAION Vision Loss
NAION is a sudden, painless loss of vision in one or both eyes caused by interrupted blood flow to the optic nerve. Research published in 2024 and 2025 suggested a possible association between GLP-1 drug use and elevated NAION risk, leading to the creation of MDL 3176 in December 2025. No U.S. label admission of NAION causation has been issued as of April 2026, but plaintiffs allege the manufacturers had knowledge of the risk.
Drugs Named in the Litigation
Claims typically involve semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity). Defendants include Novo Nordisk and Eli Lilly. Eligibility for the MDL depends on the specific drug used, the injury, and the timing.
Why Choose UnitedClaimsBureau?
UCB connects injury victims with experienced mass tort attorneys at no upfront cost. Here is what to expect when you work with us.
Pharmaceutical Case Experience
Your information is forwarded to attorneys experienced in pharmaceutical product liability and MDL litigation.
Contingency Representation
All affiliated attorneys work on a contingency fee basis - attorney fees apply only if your case results in a recovery.*
Dedicated Case Support
A dedicated case specialist will guide you through every step, from initial inquiry through attorney connection.
Confidential & Secure
Your personal and medical information is handled with strict confidentiality and is never sold to third parties.
Frequently Asked Questions
What drugs are involved in the GLP-1 lawsuits?
What injuries are alleged in the litigation?
Did the manufacturers warn about gastroparesis?
Is there a class action or MDL?
How long do I need to have used the drug to qualify?
What if I took the drug for weight loss rather than diabetes?
How long do I have to file a lawsuit?
How much does it cost to pursue a claim?
What records should I gather?
You May Have a GLP-1 Drug Claim
If you or a loved one was diagnosed with gastroparesis, intestinal obstruction, or NAION vision loss after using Ozempic, Wegovy, Mounjaro, or another GLP-1 drug, find out in minutes - confidential, no obligation.
Start Your Case Review